ICJIA releases Overdose Fatality Review Teams Literature Review

States and localities across the United States have implemented overdose fatality review teams to address the impact of the opioid crisis on their communities. Overdose fatality review teams are designed to increase cross-system collaboration among various public safety, public health, and social service agencies; identify missed opportunities and system gaps; and develop recommendations for intervention efforts in hopes of preventing future overdose deaths. However, limitations in peer-reviewed research on the effectiveness of overdose fatality review teams limit the understanding of their usefulness. This article provides a review of literature on overdose fatality review teams, including goals, recommendations, and information sharing protocols, as well as considerations from other fatality review teams.

Here’s the link.

New Study in the American Journal of Preventive Medicine on Vaping and Tobacco Quitlines

Vaping and E-Cigarettes Within the Evolving Tobacco Quitline Landscape

This article summarizes the vaping research literature as it pertains to tobacco quitlines and describes vaping assessment, treatment, and evaluation quitline practices. It also presents 2014−2018 registration data (vaping in the past 30 days, number of use days, use for quitting smoking, and intentions to quit vaping) from 24 public quitlines (23 states and District of Columbia) and 110,295 enrollees to employer-sponsored quitlines. Trends in vaping rates over time, by state, and by age group are described.

This paper outlines research and evaluation priorities to inform the future quitline treatment landscape with respect to vaping. The quitline community is positioned to increase the likelihood that vaping has a positive impact for adults who smoke through harm reduction or supporting cessation and has opportunities to expand impacts on youth and young adult vaping prevention and cessation.

Am J Prev Med 2021;60(3S2):S142−S153. © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license

Vaping and E-Cigarettes Within the Evolving Tobacco Quitline Landscape

Just posted to this Website: SPF-PFS project Final Reports

In 2012, the Substance Abuse and Mental Health Service Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP) began a project designed to address underage drinking (ages 12-17) and prescription drug misuse (ages 12-25) in high-risk communities using the Strategic Prevention Framework.

In Illinois, underage drinking was identified as a significant issue as early as 2004 through an assessment process conducted by the State Epidemiological Outcomes Workgroup (SEOW). It has continued to be a significant issue for the state through subsequent assessments in 2008 and 2012. Illinois was awarded the SPF-PFS grant in October of 2014 through a grant application submitted by the Illinois Department of Human Services (IDHS).

The SPF-PFS grant provided an opportunity to identify and fund sub-recipient communities throughout Illinois to utilize the SPF model (shown below) to target the most pressing contributing factors to underage drinking using a mix of evidence-based programs, policies and practices based on their local cultural context.

The SPF-PFS project officially concluded activities on September 29, 2019 after five years of funding. Five sites were granted continuation funding through June 30, 2020. These reports are the final reports from this project.

5 year project report:

SPF-PFS Final Evaluation Report, October 2019

Report from the five continuation SPF-PFS sites:

SPF-PFS Evaluation Report July 2020 Addendum

New CPRD Project: Substance Use Disorder Demonstration Evaluation

The Medicaid 1115 Substance Use Disorder Demonstration waiver will introduce a limited piloting of certain services that are currently not directly available to Illinois Medicaid beneficiaries. These additional services are expected to inform the state’s efforts to transform the behavioral health system in Illinois as some beneficiaries will have access to less costly community-based services, which are expected to help beneficiaries improve their health and avoid costlier services provided in an institution.  The demonstration period is July 1, 2018 through June 30, 2023 and includes 10 pilots addressing inpatient treatment, clinically managed withdrawal, case management, peer recovery support, crisis intervention, home visiting, community integration, supported employment, intensive in-home, and respite services. The project has six goals:

  1. Increased rates of identification, initiation, and engagement in treatment;
  2. Increased adherence to and retention in treatment;
  3. Reductions in overdose deaths, particularly those due to opioids;
  4. Reduced utilization of emergency departments and inpatient hospital settings for treatment where the utilization is preventable or medically inappropriate through improved access to other continuum of care services;
  5. Fewer readmissions to the same or higher level of care where the readmission is preventable or medically inappropriate; and
  6. Improved access to care for physical health and behavioral health conditions among beneficiaries.

The Center for Prevention Research and Development (CPRD) will be conducting an overall evaluation of these pilot services using Interrupted Time Series to compare trend data pre- and post-wavier and individual pilot evaluations using Propensity Score Matching analyses to compare groups. The evaluation will be conducted in partnership with the Office of Medicaid Innovation at the University of Illinois and funded by the Illinois Department of Healthcare and Family Services.